Walleye Capital LLC Denali Therapeutics Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $270,993 - $387,755	16,728 New	16,728 $358,000
Q2 2022 Aug 08, 2022	SELL	$20.88 - $35.19 $590,820 - $995,736	-28,296 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $820,584 - $1.34 Million	28,296 New	28,296 $910,000
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $398,012 - $603,158	-7,398 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $272,912 - $692,156	7,398 New	7,398 $620,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.